Exogenous hydrogen sulfide inhibits the progression of vascular dysfunction and hypertension mediated by the renin-angiotensin system in chronic kidney disease
Biochemical Pharmacology · 2026
DOI: 10.1016/j.bcp.2025.117608 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical Pharmacology, 2026. Verfasst von Jorge A Tapia-Martínez und 5 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Farmacobiología, Cinvestav-Coapa, Czda. de los Tenorios 235, Col. Granjas-Coapa, Del. Tlalpan, C.P. 14330, Ciudad de México, Mexico. Hauptthemen laut MEDLINE: Renin-Angiotensin System, Hydrogen Sulfide, Renal Insufficiency, Chronic, Hypertension. Die Arbeit nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: SECIHTI.
Abstract (Originalsprache)
Chronic kidney disease (CKD) overactivates the renin-angiotensin system (RAS), causing vascular dysfunction and hypertension. Additionally, hydrogen sulfide (H2S) is a gasotransmitter that modulates the cardiovascular system by attenuating the RAS. Therefore, this study aimed to investigate the effects of chronic administration of sodium hydrosulfide (NaHS, an exogenous H2S donor) on RAS-mediated vascular responses, oxidative stress, and progression of hypertension in rats with CKD. Thirty-two normotensive male Wistar rats were divided into four groups (n=8): 1) sham + vehicle (1 mL/kg/d, 100 mM of phosphate buffer, PBS), 2) sham + NaHS (5.6 mg/kg/d), 3) CKD induced by 5/6 nephrectomy + vehicle, and 4) CKD + NaHS. One week after surgery, pharmacological treatments began and were administered intraperitoneally daily for six weeks. Hemodynamic variables, renal function, and H2S serum levels were assessed. Additionally, H2S formation, oxidative stress, and the expression of AT1, AT2, Mas receptors, and H2S-synthesizing enzymes, along with vascular responses to angiotensin (1-7), angiotensin II and H2S were assessed in the thoracic aorta. CKS impairs: 1) RAS-mediated vascular responses; 2) downregulates Mas receptor expression; 3) upregulates AT1 and AT2 receptor expression; 4) increases H2S-mediated vascular response, 5) decreases H2S levels, tissue production of H2S and the expression of the producing enzymes; and 6) induces oxidative stress. Interestingly, NaHS treatment prevented CKD-induced impairments. In conclusion, NaHS administration protects against RAS-mediated vascular dysfunction and progression of hypertension by preventing alterations in AT1, AT2, Mas receptors, H2S-synthesizing enzymes, and oxidative stress.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departamento de Farmacobiología, Cinvestav-Coapa, Czda. de los Tenorios 235, Col. Granjas-Coapa, Del. Tlalpan, C.P. 14330, Ciudad de México, Mexico.
- Laboratorio de Metabolismo I, Departamento de Fisiología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, C.P. 07738 Ciudad de México, Mexico.
- Departamento de Farmacobiología, Cinvestav-Coapa, Czda. de los Tenorios 235, Col. Granjas-Coapa, Del. Tlalpan, C.P. 14330, Ciudad de México, Mexico. Electronic address: dcenturi@cinvestav.mx.
Förderung
- SECIHTI
Zitieren
APA
Tapia-Martínez, J. A., Silva-Velasco, D. L., Beltran-Ornelas, J. H., Sánchez-López, A., Cano-Europa, E., & Centurión, D. (2026). Exogenous hydrogen sulfide inhibits the progression of vascular dysfunction and hypertension mediated by the renin-angiotensin system in chronic kidney disease. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2025.117608
Vancouver
Tapia-Martínez JA, Silva-Velasco DL, Beltran-Ornelas JH, Sánchez-López A, Cano-Europa E, Centurión D. Exogenous hydrogen sulfide inhibits the progression of vascular dysfunction and hypertension mediated by the renin-angiotensin system in chronic kidney disease. Biochemical Pharmacology. 2026. doi:10.1016/j.bcp.2025.117608
BibTeX
@article{TapiaMartnez2026,
author = {Tapia-Martínez, Jorge A and Silva-Velasco, Diana L and Beltran-Ornelas, Jesus H and Sánchez-López, Araceli and Cano-Europa, Edgar and Centurión, David},
title = {Exogenous hydrogen sulfide inhibits the progression of vascular dysfunction and hypertension mediated by the renin-angiotensin system in chronic kidney disease},
journal = {Biochemical Pharmacology},
year = {2026},
doi = {10.1016/j.bcp.2025.117608}
}
EUVIMED